MedPath

山西金源通制药有限公司

Ownership
-
Established
2011-04-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

NMPA:18

Drug Approvals

Ketamine Hydrochloride

Product Name
盐酸氯胺酮
Approval Number
国药准字H14021800
Approval Date
Jan 13, 2025
NMPA

Meprobamate

Product Name
甲丙氨酯
Approval Number
国药准字H14021794
Approval Date
Jan 13, 2025
NMPA

Sulfadiazine

Product Name
磺胺嘧啶
Approval Number
国药准字H14021793
Approval Date
Jan 13, 2025
NMPA

Trimethoprim

Product Name
甲氧苄啶
Approval Number
国药准字H14021795
Approval Date
Jan 13, 2025
NMPA

Sulfamidinum

Product Name
磺胺脒
Approval Number
国药准字H14021661
Approval Date
Jan 13, 2025
NMPA

Paracetamol

Product Name
对乙酰氨基酚
Approval Number
国药准字H14021659
Approval Date
Sep 1, 2023
NMPA

Chloroquine Phosphate

Product Name
磷酸氯喹
Approval Number
国药准字H14021663
Approval Date
Jun 6, 2012
NMPA

Nicotinamide

Product Name
烟酰胺
Approval Number
国药准字H14021799
Approval Date
Jun 6, 2012
NMPA

Tetracycline Hydrochloride

Product Name
盐酸四环素
Approval Number
国药准字H14021668
Approval Date
Jun 6, 2012
NMPA

Dried Aluminium Hydroxide

Product Name
氢氧化铝
Approval Number
国药准字H14021666
Approval Date
Jun 6, 2012
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.